| Protection and pathology during parasite infection: IL‐10 strikes the balance SA Redpath, NM Fonseca, G Perona‐Wright Parasite immunology 36 (6), 233-252, 2014 | 83 | 2014 |
| BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression E Warner, C Herberts, S Fu, S Yip, A Wong, G Wang, E Ritch, AJ Murtha, ... Clinical Cancer Research 27 (6), 1650-1662, 2021 | 82 | 2021 |
| Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer NM Fonseca, C Maurice-Dror, C Herberts, W Tu, W Fan, AJ Murtha, ... Nature Communications 15 (1), 1828, 2024 | 33 | 2024 |
| Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping EW Warner, K Van der Eecken, AJ Murtha, EM Kwan, C Herberts, J Sipola, ... Nature Cancer 5 (1), 114-130, 2024 | 16 | 2024 |
| Functional specialization of intestinal dendritic cell subsets during Th2 helminth infection in mice SA Redpath, GA Heieis, LA Reynolds, NM Fonseca, SSY Kim, ... European Journal of Immunology 48 (1), 87-98, 2018 | 13 | 2018 |
| Genomic features of lung-recurrent hormone-sensitive prostate cancer NM Fonseca, K Van der Eecken, C Herberts, S Verbeke, SWS Ng, ... JCO precision oncology 6, e2100543, 2022 | 10 | 2022 |
| Circulating tumor DNA fraction (ctDNA%) to independently predict for clinical outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). C Maurice-Dror, N Fonseca, C Herberts, W Fan, AW Wyatt, KN Chi Journal of Clinical Oncology 39 (15_suppl), 5049-5049, 2021 | 9 | 2021 |
| A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes EJ Ritch, C Herberts, EW Warner, SWS Ng, EM Kwan, JVW Bacon, ... NPJ Precision Oncology 7 (1), 27, 2023 | 7 | 2023 |
| Restriction of viral replication, rather than T cell immunopathology, drives lethality in murine norovirus CR6-infected STAT1-deficient mice AJ Sharon, HA Filyk, NM Fonseca, RL Simister, RB Filler, W Yuen, ... Journal of Virology 96 (6), e02065-21, 2022 | 6 | 2022 |
| STAT1-dependent tolerance of intestinal viral infection HA Filyk, AJ Sharon, NM Fonseca, RL Simister, W Yuen, BK Hardman, ... bioRxiv, 2020.02. 13.936252, 2020 | 3 | 2020 |
| Biallelic loss of TP53, PTEN, and RB1 in association to aggressive clinical features and poor outcomes in metastatic castration-resistant prostate cancer (mCRPC). C Maurice-Dror, N Fonseca, C Herberts, EM Kwan, C Kollmannsberger, ... Journal of Clinical Oncology 40 (16_suppl), 5055-5055, 2022 | 2 | 2022 |
| Prostate cancer liver metastases: Genomic profiling and clinical outcomes. HN Roberts, YJR Liao, C Herberts, SH Tolmeijer, C Wang, A Riminchan, ... Journal of Clinical Oncology 43 (5_suppl), 189-189, 2025 | | 2025 |
| Abstract IA006: Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer AW Wyatt, AJ Murtha, E Warner, K Van der Eecken, EM Kwan, C Herberts, ... Cancer Research 83 (11_Supplement), IA006-IA006, 2023 | | 2023 |
| Machine-learning to predict utility of circulating tumor DNA (ctDNA) for somatic genotyping. C Herberts, W Tu, NM Fonseca, C Maurice-Dror, DJ Khalaf, M Annala, ... Journal of Clinical Oncology 41 (6_suppl), 232-232, 2023 | | 2023 |
| Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer AW Wyatt, AJ Murtha, E Warner, K Van der Eecken, EM Kwan, C Herberts, ... American-Association-for-Cancer-Research (AACR) Special Conference 83 (11 …, 2023 | | 2023 |
| 4MO Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer AJ Murtha, E Warner, K van der Eecken, E Kwan, C Herberts, J Sipola, ... Annals of Oncology 33, S1384, 2022 | | 2022 |
| Restriction of viral replication, rather than T cell immunopathology, drives lethality in MNV CR6-infected STAT1-deficient mice AJ Sharon, HA Filyk, NM Fonseca, RL Simister, RB Filler, W Yuen, ... The Journal of Immunology 208 (Supplement_1), 182.04-182.04, 2022 | | 2022 |
| A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer NM Fonseca, ME Roberts, AW Wyatt Translational Andrology and Urology 10 (10), 4009, 2021 | | 2021 |
| Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer N Fonseca, K Van der Eecken, C Herberts, S Verbeke, S Ng, N Lumen, ... Global Congress on Prostate and Bladder Cancer 2021, 2021 | | 2021 |
| Genomic features of lung-recurrent hormone sensitive prostate cancer K Van der Eecken, N Fonseca, C Herberts, S Verbeke, S Ng, N Lumen, ... Belgian Week of Pathology, 2021 | | 2021 |
